Copy to clipboard 
Himed and Adva Cera entered into a strategic partnership to create a complete development-to-production pathway for 3D-printed calcium phosphate (CaP) components used in dental, orthopedic, and spinal applications. Through this partnership, customers working with Himed to design and optimize additive bioceramic implants will have a seamless route from the design and planning through scalable production with Adva Cera.
The partnership builds on Himed’s 2024 launch of its Bioceramics Center of Excellence. Now, with Adva Cera as a scale-up partner, customers can smoothly transition from prototype to production without requalifying materials, validating a contract manufacturer, restarting development cycles, or making significant capital expenditures in printing infrastructure.
The partnership also offers a fully domestic, vertically integrated pathway from R&D through serial production, which is becoming more important to OEMs seeking to reduce dependence on overseas additive manufacturing.
“Customers who come to the Bioceramics Center of Excellence now have a clear production pathway,” explains Craig Rosenblum, President of Himed. “Partnering with Adva Cera means two leading companies can move customers from a fully optimized 3D-printed implant design into qualified, production-scale ceramic additive manufacturing with the regulatory rigor that goes with it. Their serial production capabilities will allow our customers to bring an exciting new generation of implants to patients.”
Source: Himed
